Form 4: Magnite Chief Product Officer Executes Pre-Planned Stock Option Exercises and Share Sale
Statement of Changes in Beneficial Ownership
Magnite's Chief Product Officer, Adam Lee Soroca, completed a series of pre-arranged stock option exercises and a subsequent sale of common stock on July 3, 2025, under a Rule 10b5-1 trading plan.
Summary
- Adam Lee Soroca, Chief Product Officer of Magnite, Inc., engaged in transactions on July 3, 2025, pursuant to a Rule 10b5-1 trading plan adopted on March 7, 2025.
- Soroca exercised employee stock options to acquire 2 shares of common stock at an exercise price of $1.97 per share.
- Additionally, Soroca exercised employee stock options to acquire 8,327 shares of common stock at an exercise price of $4.92 per share.
- All exercised stock options were fully vested and immediately exercisable.
- Concurrently, Soroca disposed of 42,584 shares of Magnite common stock at a price of $25.00 per share.
- Following these transactions, Soroca's direct beneficial ownership of Magnite common stock is 366,672 shares.
- Soroca retains 121,643 unexercised employee stock options with an exercise price of $4.92 per share.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While there is insider selling, it is part of a pre-planned Rule 10b5-1 trading plan, which is a common and expected practice for executives to manage liquidity and diversify their holdings, rather than a signal of negative company performance.
Positives
- The transactions were executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled and orderly disposition of shares rather than a reactive sale.
- The exercise of stock options demonstrates the executive's realization of value from previously granted compensation.
Negatives
- A significant number of shares (42,584) were sold by a key executive, which could be perceived negatively by some investors, although it was pre-planned.
Risks
- No specific new risks are introduced by this Form 4 filing; it reports standard insider transactions.
Future Outlook
The document does not provide a general future outlook for the company, but the transactions are part of a pre-planned Rule 10b5-1 trading plan, indicating a structured approach to managing executive equity.
Management Comments
- The exercise and subsequent sale were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2025.
- The stock options have fully vested and are immediately exercisable.
- Options were granted as compensation for services.
Industry Context
This Form 4 filing details routine insider transactions, specifically the exercise of stock options and subsequent sale of shares by a corporate executive. Such transactions are common for executives managing their equity compensation and personal financial planning, often facilitated by Rule 10b5-1 plans to avoid accusations of trading on material non-public information.
Comparison to Industry Standards
- This document reports individual insider trading activity and does not contain company-wide financial or operational metrics that would allow for a direct comparison to industry standards or specific comparable companies/projects.
Stakeholder Impact
- Shareholders may observe the sale of shares by a key executive, which could be interpreted in various ways, though the existence of a 10b5-1 plan typically mitigates concerns about opportunistic selling.
- Employees are not directly impacted by this specific transaction, but it reflects the executive compensation structure involving equity.
Next Steps
- No specific future actions or milestones are mentioned beyond the execution of the pre-planned trading activities.
Key Dates
| Date | Description |
|---|---|
| 03/07/2025 | Date Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 07/03/2025 | Date of the reported stock option exercises and common stock disposition transactions. |
| 07/08/2025 | Date the Form 4 filing was signed. |
| 03/15/2028 | Expiration date of a portion of the employee stock options (2 shares) that were exercised. |
| 02/20/2029 | Expiration date of a portion of the employee stock options (8,327 shares) that were exercised. |
Keywords
Magnite, MGNI, Form 4, insider trading, stock options, Rule 10b5-1, Chief Product Officer, equity compensation, stock sale, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.